For eight weeks, the team followed 21 pairs of adult identical twins -- one half of each pair consu…

uBiome isn't the only testing company that's moved into drug development. Consumer genetics company…

UBiome sells doctor-ordered tests including SmartJane, its test that looks at the vaginal microbiom…

In their study, the authors found that the risk of dying from any cause was lowered by 33% amongst …

It was around this time that uBiome began to attract the attention of investors, renowned scientist…

UBiome portrayed its tests as free to patients and claimed insurance companies would foot the bill.…

If you've ever taken a probiotic, eaten yogurt, or added pickles to your sandwich, you've taken a s…

For about six months in 2017, uBiome had an arrangement with a medical startup called Nurx, several…

I spent some time at Rock Health's Enterprise Insights Series event in NYC, where I moderated a con…

Welcome to this week's edition of Dispensed, our weekly healthcare newsletter here at Business Insi…

The company said in its bankruptcy filing that it hopes to entice an investor to purchase it for it…

uBiome's valuation depended heavily on the idea that its products could be considered health tools …

The cofounders face criminal and civil charges. They are accused of giving a false impression to in…

Cofounders and co-CEOs Zachary Apte and Jessica Richman resigned, after having been placed on admin…

Last fall, things became even more difficult. In November 2018, Gutierrez's emails to uBiome starte…

uBiome raised $105 million from investors on the promise of revealing new insights about individual…

It wasn't until roughly three years later, at the end of 2014, that the company established a lab s…

A lot of people in the industry announced new roles this week. Merck's Adam Schechter is slated to …